Clinical Trial Update: Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or Abatacept [Phase 4]

View source ↗

Summary

Phase 4 mechanistic study assessing B- and T-cell function in rheumatoid arthritis patients treated with TNF antagonists, tocilizumab, or abatacept.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Abatacept (abatacept)
• TNF-α antagonists
• Tocilizumab (tocilizumab)

Snippet

Sponsor: Dr. Larry W. Moreland | Conditions: Rheumatoid Arthritis (RA) | Phase 4 | Status: TERMINATED | Results posted: 2020-10-01